Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$78,711,400
+$17,479,553 QoQ
Shares Held
65,624
-1.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.52%
of 13F equity value
Holder Rank
#428
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Curi Capital, LLC holds $231,661,896 across 11 Drug Manufacturers - General names. LLY ranks #1 (34.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
65,624 | $78,711,400 | |
| 2 | MRK |
Merck & Co., Inc.
|
375,369 | $48,234,916 | |
| 3 | AZN |
Astrazeneca PLC
|
119,992 | $22,752,882 | |
| 4 | JNJ |
Johnson & Johnson
|
88,578 | $22,496,153 | |
| 5 | ABBV |
AbbVie Inc.
|
88,110 | $22,172,000 | |
| 6 | NVS |
Novartis AG
|
114,209 | $17,898,833 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
58,608 | $7,404,533 | |
| 8 | AMGN |
Amgen Inc
|
19,312 | $6,993,261 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,711,400 | 65,624 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $61,231,847 | 66,573 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $64,545,286 | 60,060 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $45,134,502 | 59,154 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $46,081,915 | 59,115 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $31,946,198 | 38,680 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $28,151,752 | 36,466 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,184,747 | 6,981 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $5,751,879 | 6,353 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,765,918 | 8,697 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,589,329 | 7,873 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,169,740 | 7,763 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,717,604 | 7,927 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,755,945 | 8,025 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,883,916 | 7,883 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,491,088 | 7,704 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,444,694 | 7,540 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,207,912 | 7,710 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,752,339 | 6,344 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,465,781 | 6,344 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $1,598,377 | 6,964 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,301,014 | 6,964 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,166,345 | 6,908 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,065,151 | 7,196 | Shares | Other | 2020-11-10 | |
| 2020-06-30 | $1,132,842 | 6,900 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $955,503 | 6,888 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||